CSI Market
Sign In | Register

Immunoprecise Antibodies Ltd (IPA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IPA Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Immunoprecise Antibodies Ltd adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 30 2024)
0 0 0 (Apr 30 2023)
Assets
Cash & cash equivalent2.65
Current Tax Assets Current0.32
Cash & Short-term Investments2.00
Inventories1.64
Other Current Assets4.19
Total Current Assets8.80
Equipment/Property/Plant Net12.79
Goodwill net5.89
Other Assets, Noncurrent18.47
Total Assets45.95
Liabilities
Current Accounts Payable AndAccrued Liabilities3.35
Other Liabilities, Current2.87
Total Current Liabilities6.22
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI2.96
Other liabilities, Noncurrent9.28
Total Liabilities19.97
Stockholders' Equity
Other Equity25.98
Common Stockholder's Equity25.98
Total Stockholder's Equity25.98
Liabilities & Stockholder's Equity45.95
4 historic quarters locked

Sign in to unlock the full Immunoprecise Antibodies Ltd balance sheet history.

Sign In Create Free Account

About Mindwalk Holdings Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-312694

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.